Biotech Firm Zymo Research Challenges Qiagen in Antitrust Legal Dispute

Biotech company Zymo Research Corp. is currently defending itself in a legal battle involving antitrust counterclaims against its German competitor, Qiagen GMBH. The dispute revolves around Qiagen’s infringement suit, which Zymo alleges is an attempt to tarnish their reputation. According to Zymo, the company had proposed to demonstrate that it did not infringe upon Qiagen’s technology, but claims that Qiagen turned a blind eye and proceeded with litigation. For a detailed exposition of the ongoing legal proceedings, more information is available on Law360.